# TRex Bio Inc. (TRXB)

Source: https://www.quantisnow.com/company/TRXB
Generated: 2026-11-18T11:00:55.834Z

- Ticker: TRXB
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2026
- SEC CIK: 0002139097
- Website: https://trex.bio/

## About

TRexBio is a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines designed to restore immune balance and promote tissue repair to address unmet needs of patients with autoimmune and inflammatory diseases. TRexBio's Deep Biology Platform decodes Treg functionality in human tissue, mapping key drivers of immune dysregulation and uncovering novel targets and insights that inform drug discovery and translational efforts. This platform has generated multiple therapeutic development candidates across TRexBio's wholly owned pipeline and through collaborations with leading pharmaceutical partners. TRexBio is led by an experienced management team and headquartered in South San Francisco, California.

## Latest TRXB news and filings

- 2026-11-13 21:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by TRex Bio Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-trex-bio-inc-6790984)
- 2026-11-13 21:04 UTC [SEC Form 8-K] [TRex Bio Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/trex-bio-inc-filed-sec-form-8-k-results-of-operations-6790435)
- 2026-11-13 21:02 UTC [Earnings] [TRexBio Reports Third Quarter 2026 Financial Results and Recent Business Highlights](https://www.quantisnow.com/insight/trexbio-reports-third-quarter-2026-financial-results-and-recent-business-6790352)
- 2026-11-03 11:56 UTC [Analyst Coverage Initiated] [Cantor Fitzgerald initiated coverage on TRex Bio, Inc.](https://www.quantisnow.com/insight/cantor-fitzgerald-initiated-coverage-on-trex-bio-inc-6768318)
- 2026-11-03 11:38 UTC [Analyst Coverage Initiated] [Stifel initiated coverage on TRex Bio, Inc. with a new price target](https://www.quantisnow.com/insight/stifel-initiated-coverage-on-trex-bio-inc-with-a-new-6768297)
- 2026-11-03 11:38 UTC [Analyst Coverage Initiated] [Analyst initiated coverage on TRex Bio, Inc. with a new price target](https://www.quantisnow.com/insight/analyst-initiated-coverage-on-trex-bio-inc-with-a-new-6768296)
- 2026-11-02 12:38 UTC [Analyst Coverage Initiated] [Wedbush initiated coverage on TRex Bio, Inc. with a new price target](https://www.quantisnow.com/insight/wedbush-initiated-coverage-on-trex-bio-inc-with-a-new-6766150)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/TRXB
- Earnings history: https://www.quantisnow.com/earnings/TRXB
- Dividend history: https://www.quantisnow.com/dividends/TRXB
- Insider transactions: https://www.quantisnow.com/insiders/TRXB
- Options chain: https://www.quantisnow.com/options/TRXB
- SEC 8-K filings only: https://www.quantisnow.com/company/TRXB/8-k
- RSS and alerts for TRXB: https://www.quantisnow.com/docs/rss-feeds.md
